Literature DB >> 1764078

Expression of human T-cell leukemia virus type I protease in Escherichia coli.

T Hayakawa1, Y Misumi, M Kobayashi, Y Ohi, Y Fujisawa, A Kakinuma, M Hatanaka.   

Abstract

Human T-cell leukemia virus type I (HTLV-I) genome is believed to encode its own protease, although the protease has not yet been detected. To identify the HTLV-I protease, an in-frame gag (3' portion)-prt region was expressed in Escherichia coli. The 14-kDa product was detected using antisera against a synthetic peptide mimicking the fragment of HTLV-I protease, although the molecular weight of the primary translational product was 27,000. A cell extract had a proteolytic activity to cleave a synthetic peptide substrate containing the cleavage site of gag p19/p24 at the correct site in vitro. Replacement of the putative active site Asp-64 with Gly abolished both in vivo processing activity and in vitro proteolytic activity. These results suggest that the 14-kDa product is the mature enzymatically active HTLV-I protease generated through posttranslational autoprocessing in E. coli.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764078     DOI: 10.1016/0006-291x(91)92077-w

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Efficient expression and rapid purification of human T-cell leukemia virus type 1 protease.

Authors:  Y S Ding; S M Owen; R B Lal; R A Ikeda
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

2.  Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity.

Authors:  A Saiga; T Tanaka; S Orita; A Sato; S Sato; T Hachisu; K Abe; Y Kimura; Y Kondo; T Fujiwara
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  The Effects of Side-Chain Configurations of a Retro-Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease.

Authors:  Chiyuki Awahara; Daiki Oku; Saki Furuta; Kazuya Kobayashi; Kenta Teruya; Kenichi Akaji; Yasunao Hattori
Journal:  Molecules       Date:  2022-03-02       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.